Effectiveness of an NK1 Antagonist in Decreasing Symptoms of Post-Traumatic Stress Disorder

This study has been completed.

Study NCT00211861 Information provided by National Institute of Mental Health (NIMH)

First Received: September 15, 2005 Last Updated: April 8, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	December 2008
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

No publications provided by National Institute of Mental Health (NIMH)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Mathew SJ, Vythilingam M, Murrough JW, Zarate CA Jr, Feder A, Luckenbaugh DA, Kinkead B, Parides MK, Trist DG, Bani MS, Bettica PU, Ratti EM, Charney DS. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur Neuropsychopharmacol. 2011 Mar;21(3):221-9. Epub 2010 Dec 30.